Canadian Blood and Marrow Transplant Group
Cure Stems From Here
Meetings
12th Biennial CBMTG Conference in Vancouver - April 7-10, 2010
Co-Chairs:
Keith Humphries, MD, PhD, Senior Scientist, Terry Fox Laboratory, British Columbia Cancer Agency; Professor, Department of Medicine, University of British Columbia
Thomas Nevill, MD, FRCPC, Clinical Professor, Leukemia/BMT Program of British Columbia
Dr. Nevill received his MD from the University of Toronto in 1983. He did his Internal Medicine/Hematology training in Halifax, NS and a Leukemia/BMT Fellowship in Vancouver, BC. He established the first BMT Program in Atlantic Canada in 1991 before returning to Vancouver where he is a Clinical Professor in the Division of Hematology. In 2006, he became the Clinical Director of the Leukemia/BMT Program of British Columbia. He is the Vice-President of the Canadian Hematology Society and maintains a research interest in myelodysplastic syndromeand graft-versus-host disease.
Session Topics include:
|
|
Click Here to View the Preliminary Program
Don't Miss the Pre-Conference Day -April 7th!
Nursing Session:
Wednesday, April 7th- 12:30pm-3:15pm
Here are the Clues - Can you Solve the Mystery? Issues in Vascular Access:
Expert nursing care of patients with vascular access devices requires excellent assessment, clinical and advocacy skills, as well as highly developed critical thingking. This workshop will cover venous anatomy, appropriate device selection, prevention and management of complications, infection control issues and parenteral chemotherapy. Participants will be presented with real-life clinical scenarios ("clues") and will be invited to discuss and share their experiences with the group. Evidence-based information will be used to "solve the mysteries"! Workshop facilitator, Inara Karrei (B.Sc, M.A) has over 20 years of experience in oncology, hematology and bone marrow transplant. She is currently the Nurse Educator for the systemic therapy and radiation therapy departments of the Ottawa Hospital Cancer Centre.
Cytogenetics, Flow Cytometry and FISH: Implications for Prognosis and Treatment:
"Cytogenetics", "Flow Cytometry" and "FISH" testing are commonly used in the field of hematologic malignancies ... but what do the results mean and what are the implications for patients? In this session, Dr. Stephen Nantel will explain how to intrepret the information in these reports and how this information is used to treat and counsel patients. Dr. Stephen Nantel (MD, FRCPC) is a senior staff member of the Leukemia/BMT Program of BC and a Clinical Professor, Department of Medicine, University of British Columbia. As a former Hematology Training Program Director and Chief Examiner (Hematology) for the Royal College of Physicians and Surgeons of Canada, he has a special interest in Hematology education and certification. His clinical interests are in the management of patients with acute leukemias especially APL and ALL.
Cryopreservation Workshop
Wednesday, April 7th- 2:00pm-4:00pm
Dump Freeze Protocol- Mike Halpenny
Dump Freeze, directly into liquid nitrogen vapour, is used to cryopreserve all cellular therapy products at the CBS Ottawa Stem Cell lab. Discussion will include validation method, standard operating procedures, cryopreservation solution contributions, additional notes.
Principles of Cryoprotection: Can we say No to DMSO? Locksley McGann
The Importance of the Cooling Profile, Documentation and Validation- Kelly Murphy
Recent validation exercises in the Edmonton Stem Cell Lab revealed that component cooling profile is influenced by a number of factors. The lessons learned through this experience are shared in the context of the basic principles of cryobiology.
Gail Sharpe - Freezer Storage – How Much is Enough?
This is an account of an HPC storage freezer failure. The cells were moved to a warmer temperature and testing was performed to determine the effect on the cells. There will be a focus on lessons learned.
CBMTG Clinical Trials Network Meetings:
Wednesday, April 7th
8:00am-12:00am CBMTG 0801 Investigator Meeting (sign in at 7:30am).
3:30pm-5:00pm CBMTG-CTN Meeting (Review of Current Trials/New Proposals)
CBMTG Members receive discounted registration to the CBMTG meeting. Click here for further membership information.
Registration information or to register
